Andersen-Tawil syndrome natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:


===Complications===
===Complications===
*Common complications of [[Andersen-Tawil syndrome]] include:<ref name="pmid24861851">{{cite journal| author=Kostera-Pruszczyk A, Potulska-Chromik A, Pruszczyk P, Bieganowska K, Miszczak-Knecht M, Bienias P | display-authors=etal| title=Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement. | journal=Muscle Nerve | year= 2015 | volume= 51 | issue= 2 | pages= 192-6 | pmid=24861851 | doi=10.1002/mus.24293 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24861851 }}</ref><ref name="pmid24047492">{{cite journal| author=Fernlund E, Lundin C, Hertervig E, Kongstad O, Alders M, Platonov P| title=Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome. | journal=Ann Noninvasive Electrocardiol | year= 2013 | volume= 18 | issue= 5 | pages= 471-8 | pmid=24047492 | doi=10.1111/anec.12074 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24047492  }}</ref><ref name="pmid17221872">{{cite journal| author=Haruna Y, Kobori A, Makiyama T, Yoshida H, Akao M, Doi T | display-authors=etal| title=Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome. | journal=Hum Mutat | year= 2007 | volume= 28 | issue= 2 | pages= 208 | pmid=17221872 | doi=10.1002/humu.9483 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17221872  }}</ref><ref name="pmid17272325">{{cite journal| author=Peters S, Schulze-Bahr E, Etheridge SP, Tristani-Firouzi M| title=Sudden cardiac death in Andersen-Tawil syndrome. | journal=Europace | year= 2007 | volume= 9 | issue= 3 | pages= 162-6 | pmid=17272325 | doi=10.1093/europace/eul188 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17272325  }}</ref><ref name="pmid24383070">{{cite journal| author=Nguyen HL, Pieper GH, Wilders R| title=Andersen-Tawil syndrome: clinical and molecular aspects. | journal=Int J Cardiol | year= 2013 | volume= 170 | issue= 1 | pages= 1-16 | pmid=24383070 | doi=10.1016/j.ijcard.2013.10.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24383070  }}</ref><ref name="pmid24827800">{{cite journal| author=Kukla P, Biernacka EK, Baranchuk A, Jastrzebski M, Jagodzinska M| title=Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome. | journal=Curr Cardiol Rev | year= 2014 | volume= 10 | issue= 3 | pages= 222-8 | pmid=24827800 | doi=10.2174/1573403x10666140514102528 | pmc=4040873 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24827800 }}</ref>
*Common complications of [[Andersen-Tawil syndrome]] include:<ref name="pmid24861851">{{cite journal| author=Kostera-Pruszczyk A, Potulska-Chromik A, Pruszczyk P, Bieganowska K, Miszczak-Knecht M, Bienias P | display-authors=etal| title=Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement. | journal=Muscle Nerve | year= 2015 | volume= 51 | issue= 2 | pages= 192-6 | pmid=24861851 | doi=10.1002/mus.24293 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24861851  }}</ref>
**Syncope or presyncopal attacks
**Ventricular arrhythmia
**Exercise-induced nonsustained bidirectional ventricular tachycardia
**QT or QU prolongation with polymorphic ventricular tachycardia which are life-threatening
**Sudden cardiac death
**Sudden cardiac death
**Neurological or neurocognitive defects
**[Complication 3]


===Prognosis===
===Prognosis===

Revision as of 14:54, 3 February 2020

Andersen-Tawil syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Andersen-Tawil syndrome from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Andersen-Tawil syndrome natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Andersen-Tawil syndrome natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Andersen-Tawil syndrome natural history, complications and prognosis

CDC on Andersen-Tawil syndrome natural history, complications and prognosis

Andersen-Tawil syndrome natural history, complications and prognosis in the news

Blogs on Andersen-Tawil syndrome natural history, complications and prognosis

Directions to Hospitals Treating Andersen-Tawil syndrome

Risk calculators and risk factors for Andersen-Tawil syndrome natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

If left untreated, patients with Andersen-Tawil syndrome may progress to develop periodic paralysis, cardiac arrhythmias and can lead to the death of the patient. Common complications of Andersen-Tawil syndrome include neuromuscular symptoms and malignant hyperthermia. Prognosis is generally range from good to poor.

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

  • Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
  • Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
  • The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
  • [Subtype of disease/malignancy] is associated with the most favorable prognosis.
  • The prognosis varies with the [characteristic] of the tumor; [subtype of disease/malignancy] has the most favorable prognosis.

References

  1. Tawil R, Ptacek LJ, Pavlakis SG, DeVivo DC, Penn AS, Ozdemir C; et al. (1994). "Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features". Ann Neurol. 35 (3): 326–30. doi:10.1002/ana.410350313. PMID 8080508.
  2. Sansone V, Griggs RC, Meola G, Ptácek LJ, Barohn R, Iannaccone S; et al. (1997). "Andersen's syndrome: a distinct periodic paralysis". Ann Neurol. 42 (3): 305–12. doi:10.1002/ana.410420306. PMID 9307251.
  3. Kostera-Pruszczyk A, Potulska-Chromik A, Pruszczyk P, Bieganowska K, Miszczak-Knecht M, Bienias P; et al. (2015). "Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement". Muscle Nerve. 51 (2): 192–6. doi:10.1002/mus.24293. PMID 24861851.

Template:WH Template:WS